日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluating the association of antibiotic spectrum and treatment responses of cystic fibrosis pulmonary exacerbations

评估抗生素谱与囊性纤维化肺部急性加重治疗反应之间的关联

Somayaji, Ranjani; Cogen, Jonathan D; VanDevanter, Donald; LiPuma, John J; West, Natalie E; Sanders, Don B; Gerber, Jeffrey S; Kronman, Matthew P; Goss, Christopher H; Flume, Patrick A; Heltshe, Sonya L

Correlates of FEV₁ deficit in pulmonary exacerbations of cystic fibrosis and associated clinical outcomes

囊性纤维化肺部急性加重期FEV₁不足的相关因素及相关临床结局

McElvaney, Oliver J; Heltshe, Sonya L; Sanders, Don B; West, Natalie E; Fogarty, Barbra; VanDevanter, Donald R; Flume, Patrick A; Goss, Christopher H

Heterogeneity of CFTR modulator-induced sweat chloride concentrations in people with cystic fibrosis

囊性纤维化患者中CFTR调节剂诱导的汗液氯化物浓度的异质性

Zemanick, E T; Emerman, I; McCreary, M; Mayer-Hamblett, N; Warden, M N; Odem-Davis, K; VanDevanter, D R; Ren, C L; Young, J; Konstan, M W

Longitudinal bacterial prevalence in cystic fibrosis airways: Fact and artifact

囊性纤维化气道细菌纵向流行率:事实与假象

VanDevanter, D R; LiPuma, J J; Konstan, M W

Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations

囊性纤维化肺部急性加重STOP2研究中呼吸道病毒感染的患病率和临床影响

Thornton, Christina S; Caverly, Lindsay J; Kalikin, Linda M; Carmody, Lisa A; McClellan, Scott; LeBar, William; Sanders, Don B; West, Natalie E; Goss, Christopher H; Flume, Patrick A; Heltshe, Sonya L; VanDevanter, Donald R; LiPuma, John J

Adjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic Fibrosis

辅助全身性皮质类固醇治疗囊性纤维化肺部急性加重

McElvaney, Oliver J; Heltshe, Sonya L; Odem-Davis, Katherine; West, Natalie E; Sanders, Don B; Fogarty, Barbra; VanDevanter, Donald R; Flume, Patrick A; Goss, Christopher H

Sustainability and transferability of good practices for children's health promotion, obesity and NCDs prevention and responsive parenthood

儿童健康促进、肥胖和非传染性疾病预防以及积极养育子女的良好做法的可持续性和可推广性

VanDevanter, Nancy; Vu, Milkie; Nguyen, Ann; Nguyen, Trang; Van Minh, Hoang; Nguyen, Nam Truong; Shelley, Donna R; Giusti, A; Cattaneo, C; Scardetta, P; Palermo, V; Zambri, F

Characterizing CFTR modulated sweat chloride response across the cf population: Initial results from the CHEC-SC study

囊性纤维化患者群体中CFTR调节的汗液氯化物反应特征分析:CHEC-SC研究的初步结果

Mayer-Hamblett, N; Zemanick, E T; Odem-Davis, K; VanDevanter, D; Warden, M; Rowe, S M; Young, J; Konstan, M W; For-The-Chec-Sc-Study-Group

Impact of lumacaftor/ivacaftor and tezacaftor/ivacaftor on treatment response in pulmonary exacerbations of F508del/F508del cystic fibrosis

lumacaftor/ivacaftor 和 tezacaftor/ivacaftor 对 F508del/F508del 囊性纤维化肺部急性加重治疗反应的影响

McElvaney, Oliver J; Heltshe, Sonya L; Odem-Davis, Katherine; West, Natalie E; Sanders, Don B; Fogarty, Barbra; VanDevanter, Donald R; Flume, Patrick A; Goss, Christopher H

Willingness of people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor (ETI) to participate in randomized modulator and inhaled antimicrobial clinical trials

接受 elexacaftor/tezacaftor/ivacaftor (ETI) 治疗的囊性纤维化患者参与随机调节剂和吸入抗菌药物临床试验的意愿

VanDevanter, D R; Zemanick, E T; Konstan, M W; Ren, C L; Odem-Davis, K; Emerman, I; Young, J; Mayer-Hamblett, N